Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical ...
Stakeholders responding to recent draft guidance from the US Food and Drug Administration (FDA) on the use of minimal ...
The US Food and Drug Administration (FDA) and the generic drug industry have reached agreement on some areas amid ...
Regulatory Recon is our regular intelligence briefing for the regulatory affairs space, bringing you the top regulatory, ...
The European Medicines Agency has finalized its reflection paper on a tailored clinical approach to biosimilar development, ...
The US Food and Drug Administration (FDA) has cited a medical device manufacturer and a contract drug testing laboratory for ...
Learn from faculty at one of the world’s most prestigious business schools in an environment dedicated to preparing ...
RAPS and Elemed are pleased to release the 2nd edition of this ground-breaking white paper, which provides a snapshot of the ...
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug, and medical device regulation and what we’re reading from around the web. This week, ...
Following the trend of other regulators, the European Medicines Agency (EMA) is taking steps to reduce the need for animal testing. The agency has issued a draft qualification opinion for a new ...
Understand the technical challenges and regulatory expectations faced by biopharmaceutical development scientists and regulatory professionals during the product development lifecycle.
Two former US Food and Drug Administration (FDA) officials have commented on and proposed changes to the agency’s recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results